Literature DB >> 18838922

Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study.

Guy D Eslick1, Nicholas J Talley.   

Abstract

BACKGROUND: We aimed to determine the prevalence of gastroesophageal reflux disease (GERD) and associated risk factors, and assess quality of life (QoL) in relation to the frequency and severity of reflux symptoms.
METHODS: A random sample of 1000 residents of Western Sydney were mailed a validated self-report questionnaire. GERD symptoms, risk factors, psychologic distress, QoL, and demographics were measured.
RESULTS: The response rate was 73% (n=672; mean age, 46 y; 52% female). A total of 78 [12%, 95% confidence interval (CI): 9-14] had GERD (at least weekly heartburn and/or acid regurgitation). Independent risk factors for GERD were high cholesterol [odds ratio (OR) =3.28, 95% CI: 1.42-7.57, P=0.005] and current smoker (OR=2.47, 95% CI: 1.07-5.70, P=0.03). Anxiety, depression, and neuroticism were not risk factors. Worse physical functioning was the only QoL domain associated with GERD (OR=0.98, 95% CI: 0.97-0.99, P=0.006). QoL was significantly impaired regardless of the severity of GERD for the QoL domains physical function, body pain, vitality, and social function. The frequency of heartburn and acid regurgitation were not associated with significantly reduced QoL domain scores.
CONCLUSIONS: Cardiac risk factors (high cholesterol and smoking) were independently associated with GERD. Increasing GERD symptom severity is associated with worse QoL scores, whereas GERD symptom frequency did not impact the QoL scores.

Entities:  

Mesh:

Year:  2009        PMID: 18838922     DOI: 10.1097/MCG.0b013e31815ea27b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  24 in total

Review 1.  Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Sander Veldhuyzen van Zanten; Ron Bridges
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

Review 2.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 3.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 4.  Environmental - lifestyle related factors.

Authors:  Sabine Roman; John E Pandolfino
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

5. 

Authors:  Tharindu Fernando; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

6.  Lactobacillus species shift in distal esophagus of high-fat-diet-fed rats.

Authors:  Xin Zhao; Xiao-Wei Liu; Ning Xie; Xue-Hong Wang; Yi Cui; Jun-Wen Yang; Lin-Lin Chen; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

7.  Management of gastroesophageal reflux disease in pediatric patients with cerebral palsy.

Authors:  Tharindu Fernando; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

8.  Prevalence of Psychiatric Comorbidity in Symptomatic Gastroesophageal Reflux Subgroups.

Authors:  Mustafa Melih Bilgi; Rukiye Vardar; Esra Yıldırım; Baybars Veznedaroğlu; Serhat Bor
Journal:  Dig Dis Sci       Date:  2016-08-26       Impact factor: 3.199

9.  Are rice and spicy diet good for functional gastrointestinal disorders?

Authors:  Sutep Gonlachanvit
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

10.  Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.

Authors:  Jonas F Ludvigsson; Pertti Aro; Marjorie M Walker; Michael Vieth; Lars Agréus; Nicholas J Talley; Joseph A Murray; Jukka Ronkainen
Journal:  Scand J Gastroenterol       Date:  2013-05-14       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.